Barr-virus-determined nuclear antigen (EBNA) positive cells. The patients respond with antibody production against viral capsid antigen (VCA), early antigen (EA) and, eventually, against EBNA in that temporal order. Later, as the acute infection subsides, the number of virus-carrying cells falls (20) and stays at a low level in a latent form over a patient's lifetime. After the acute disease, antibodies against VCA and EBNA persist, whereas the anti-EA response fades away.
The mechanisms that keep the number of virus-producing cells at a relatively low level are not known. If NK cells play a role, one would expect that EBV-DNAcarrying cells that have entered the viral cycle would be more sensitive to NK lysis than the progenitor cells that carry the viral genome in a latent form.
EBV-earrying lymphoblastoid and Burkitt's lymphoma-derived lines all contain the viral genome in multiple copies (21) (22) (23) , and express EBNA (24) . However, only a very small proportion, if any, of the cells enter the viral cycle at a given time. This proportion can be dramatically increased, however, by superinfecting EBV-carrying cultures with massive doses of the P3HR-1 substrain of EBV (25) , or by treatment with certain chemical inducers, such as n-butyrate (26) (27) (28) (29) (30) .
In this paper, we show that both methods of EBV-cycle induction lead to an increase in the NK sensitivity of EBV-carrying cell lines. Interestingly, superinfection with a transforming virus prototype, B95-8, which does not increase the fraction of cells entering the viral cycle, had no such effect (with one exception).
Materials and Methods
Virus. Infectious EBV from the P3HR-1 cell line was provided by the Pfizer Chemical Div., Pfizer, Inc., New York, under a contract from the Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Md.
The virus was received in wet pack, frozen, and stored at -70°C. These preparation usually induced 20-30% EA-positive cells in the Raji line 48 h after superinfection with a 1:75 dilution. B95-8 virus was concentrated by centrifugation at 9,000 rpm for 2 h from the supernate of B95-8 cells; it was frozen and stored at -70°C. Its infectivity was assayed by exposing the EBVnegative Ramos cell line to 1:5 and 1:10 dilutions; 24-27% EBNA-positive cells were induced after 48 h (31).
Cell Lines. All cells were propagated as suspension cultures in RPMI-1640 medium with 8% fetal calf serum (Grand Island Biological Co., Grand Island, N. Y.) and subcuhured twice weekly. Raji (32) and Daudi (33) originated from Burkitt's lymphoma, B JAB (34) was derived from an EBV-negative Burkitt's lymphoma, Molt-4 (35) was derived from an acute lymphocytic leukemia patient, K562 (36) was established from a patient with chronic myeloid leukemia. Both AT-A-CL7-III and NAD-7 were established in our laboratory, by transforming the blood lymphocytes of an ataxia teleangiectasia patient and a healthy adult. Both lines were transformed with the B95-8 strain of EBV.
Superinfection of Cells.
Cells were suspended at a concentration of 1 X 10 6 per ml and infected with the appropriately diluted virus for 1 h at 37°C. The cells were resuspended in culture medium at a concentration of 0.5 × 106 per ml and incubated at 37°C for 24 h. Cells superinfected with P3HR-1 virus are designated by adding the symbol (V).
Demonstration of EBV-associated Antigens. EA was stained on acetone-fixed smears with an fluorescein isothiocyanate-conjugated IgG fraction of EA-and VCA-positive human serum at a dilution of 1:40 as previously described (37) . EBNA was stained by anti-complement immunofluorescence on methanol-acetone-fixed smears (24) .
Lymphocytes. Lymphocytes were separated from heparinized blood by the Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) -Isopaque (Nyeggard, & Co. AS, Oslo, Norway) method of B6yum (38) .
Cytotoxic Assay. ~XChromium release tests were performed in a Falcon II microplate (Falcon Labware, Div. Becton, Dickinson & Co., Oxnard, Calif.) (39) . Peripheral blood lymphocytes (PBL) were used as effector cells at a 100:1 effector target ratio. 5 × 10 a target cells were added to each well in a vol of 0.1 ml followed by the addition of 5 × 105 PBL per 0.1 ml. Finally, 0.1 ml medium was added to each well to give a final concentration of 0.3 ml per well. Test combinations were set up in quadruplicate. Control wells containing only target cells were included in each experiment to determine maximum and spontaneous release. The microplate was incubated at 37°C in a 5% CO2 atmosphere for 4 h. After incubation, the plate was centrifuged at 1,500 rpm for 5 min. 0.1 ml of the cell-free supemate was removed. The specific 51Cr release was determined according to the following formula: release in test -spontaneous release x 100. maximal release --spontaneous release Experiments in which the spontaneous release was >25% were not evaluated.
Cold-Target Inhibition of Cytotoxicity. The cytotoxic test was performed as above after graded numbers of unlabeled cells were added simultaneously with the target cells in 0.1 ml medium. The microplate was rocked on a Bellco (Bellco Glass, Inc., Vineland, N. J.) rocker at a slow speed during the duration of the assay. The results were expressed as the percentage of inhibition.
Induction of Cells by n-Butyrate. 3 mM n-butyrate was added to P3HR-1 cells suspended at a concentration of 0.4 × 10~ per ml for various time intervals.
Virus Neutralization. P3HR-1 virus was incubated with l:10 anti-EBV (VCA) -positive or -negative sera at 4°C for 2.5 h. The final concentration of the virus was the same as in the superinfection experiments. After incubation, the infection experiment was performed as usual.
Kinetics. Aiiquots of Raji cells from one pool were removed and infected at different time intervals with the P3HR-1 virus derived from the same batch. All cells were harvested simultaneously, 51Cr labeled, and exposed to the same effector lymphocytes.
Results

P3HR-1 Virus Superinfection
Increases the NK Sensitivity of Raft Cells. Raji cells are relatively resistant to NK killing (40) . EBV (P3HR-1 strain) superinfection increases the NK sensitivity of Raji cells after 24 h (Fig. 1) . This was observed in all 25 experiments that were carried out. The mean percent specific chromium release increased from 3.4 to 27%. There was no increase of the background 51Cr release. The addition of human serum instead of fetal calf serum did not influence the results. Raji cells superinfected with different concentrations of virus showed increased specific 51Cr release depending on the virus concentration (Fig. 2) .
The Virus-induced Increase in NK Sensitivity Depends on the Efficiency of Infection. P3HR-1 virus superinfection induced the entry of a certain proportion of Raji cells into the viral cycle, as indicated by the appearance of EA. To examine if there was any relationship between the efficiency of the superinfection, as measured by the EAinduction criterion, and the increased NK sensitivity, aliquots of the culture tested for NK sensitivity were fixed 48 h after infection and the frequency of EA-positive cells was determined. The relationship between the frequency of EA-positive cells and NK sensitivity is shown in Fig. 3 . The results suggest that the sensitivity of the target cells depends on the initiation of the viral cycle (although not necessarily on EA synthesis as such).
Virus Neutralization Test. Because superinfection was carried out with concentrated, virus-containing P3HR-1 culture supernate and not with purified virus, it had to be checked whether the virus itself could be held responsible for the increased NKsensitivity. Infection tests were therefore also performed with preparations exposed to EBV antibody-positive human serum, for 2½ h before infection (Table I) . EBV antibody-positive, but not negative, serum abolished the ability of the virus-containing supernates to increase the NK sensitivity, indicating that the virus was responsible for the effect.
Changes in NK Sensitivity in Raft Cells as a Function of Time After Superinfection. The
NK sensitivity of P3HR-l-virus-superinfected Raji cells increased by 12 h, peaked at 24 h, and declined subsequently (Fig. 4) . Because viral attachment to the EBV surface receptors is maximal immediately after the infection (41) and declines thereafter, the sensitivity is not merely a result of the presence of attached virus particles on the cell surface. assumed that the increased NK sensitivity of the EBV-superinfected Raji cells is a result of the recognition of EBV-associated antigens by immune lymphocytes, or of an antibody-dependent cell-mediated (ADCC) mechanism. In the latter case, antibodies would be secreted during incubation. Therefore the cytotoxicity of effector cells derived from EBV-seropositive and seronegative donors was compared in four experiments (Table III) . There was no significant difference between the killing effect of cells from EBV,positive and -negative donors. Thus, although EBV is responsible for the induction of NK sensitivity (as indicated by the virus neutralization test), cytotoxicity is not a result of a preimmunized state of the lymphocyte donor against EBV.
Superinfection of Other Cell
Cold-Target Inhibition Tests. The question arose whether the killing of the EBVsuperinfected Raji was a result of the effector-target interaction operating also in the Infected with virus exposed to EBV 12 5 antibody-positive serum P3HR-I virus was incubated with EBV antibody-positive serum (VCA titer: 160, EA: < 10, EBNA: 80) and EBV antibody-negative serum (VCA titer: < 10, EA: < 10, EBNA: < 2) for 2.5 h before infection. known human NK system. As one approach toward this question, we have performed cold target inhibition tests with two cell lines known for their high NK-sensitivity, Molt-4 and K562. The cell populations used for competition were tested for their NK sensitivity in parallel. We could readily confirm the high NK sensitivity of these lines (specific 51Cr release: 35-40% at a 100:1 effector:target cell ratio). B JAB had low NK sensitivity (6-9%), Daudi and Raji were even lower (1-3%), and NAD-7 was insensitive (0-1%). In the competition test, cytotoxicity against Raji (V) was inhibited by the homologous cell, Raji (V) itself, and by Molt-4 and K562 (Fig. 5) . B JAB inhibited the cytotoxicity to a lesser extent; NAD-7 and Daudi did not inhibit at all. It is of interest that the uninfected Raji showed a slight but significant inhibition. Thus with the exception of Raji, the capacity of the cell lines to inhibit the killing of Raji (V) was directly related to their NK susceptibility as targets.
We have also performed the reciprocal experiment with Molt-4 as targets. Cellmediated lysis of the Molt-4 could be inhibited by both Raji (V) and Daudi (V), whereas uninfected Raji and Daudi were ineffective (Fig. 6 ). In keeping with their high NK sensitivity, Moh-4 and K562 were more efficient competitors than Raji (V). It is noteworthy that uninfected Raji cells did not compete in this system although they did compete against superinfected Raji cells as already mentioned (compare nor does it induce any detectable EA. We tested the effect of transforming-B95-8 viral superinfection on the NK sensitivity of Raji cells. B95-8 virus was titrated for infectivity by its ability to induce EBNA in the EBV-negative Ramos line (31) . Two different virus pools were tested, one of them at three different concentrations. B95-8 virus exposure did not increase the NK sensitivity of Raji cells (Table IV) . Daudi cells showed a certain increase in NK sensitivity although this was less dramatic than with P3HR-1 virus (compare Table II) . EA values in the B95-8-infected Daudi cells, however, were not increased from the uninfected control cells (1%).
Comparison of the Cytotoxicity of Lymphocytes Obtained from EB V Antibody-positive and EB V Antibody-negative Donors
Virus Induction with n-Butyrate. Some EBV-carrying cells can be induced to express EA by iododeoxyuridine, bromodeoxyuridine, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), cyeloheximide, and n-butyrate (26) (27) (28) (29) (30) . P3HR-1 cells could be induced more efficiently than Raji by n-butyrate as indicated by the appearance of EA (26) . We have therefore selected P3HR-1 cell to test the effect of n-butyrate treatment on cytotoxic sensitivity. The experiment was complicated by the fact that P3HR-1 cells were sensitive to NK lysis. Their sensitivity was highly variable. This variation may be related to the variable proportion of the cells that enter spontaneously the lytic cycle. In spite of this variation, the experiments showed that n-butyrate induction 4 X 10 ~ P3HR-1 cells per ml were incubated with 3 mM n-butyrate for different time intervals. Sensitivity to killing by blood lymphocytes was measured as specific 51Cr release at a 100:1 effector:target cell ratio in a 4-h assay. regularly increased cytotoxicity (Table V) , as assessed after 24-48 h. When followed as a function of time during a 2-d period, sensitivity increased with time ( Fig. 7) , in parallel with the EA values (Table VI) . Thus, induction of the EBV cycle by both chemical and viral agents increases the NK sensitivity of the human lymphoid lines. The nature of the killing is unknown. The sensitive cell panel does not provide any clue for the cell surface structure that serves as the target. The majority of investigators agree that the NK system lacks selectivity. Lymphocytes of different individuals differ in their killing efficiency but the ranking order of relative sensitivity remains similar when a spectrum of targets are confronted with different effector cells.
Cell lines can be divided into three categories: (a) sensitive in short-term assay; (b) sensitive only in long-term assay; (c) insensitive. The difference between the first and second categories is probably quantitative, in that a target displays sensitivity to effectors with a certain threshold level of activity. During prolonged interaction, the potentially cytotoxic lymphocytes are activated to kill with a higher efficiency.
We have shown that the relatively low NK sensitivity of human EBV-carrying Bcell lines can be increased by superinfection with the abortively lytic P3HR-1 virus or with n-butyrate, but not with the transforming EBV-prototype, the B95-8 virus. The increased NK sensitivity was maintained in the presence of Ara-C (Unpublished results.). When considered together with the kinetics of the effect, the findings suggest that the increased vulnerability by NK cells may develop in relation to the entry of the cells into the viral cycle. If this mechanism also operates in vivo, it may obviously help in restricting the spread of virus, by killing potential virus-producing cells before they reach the stage where they can release mature virus particles. Lymphocytotoxicity was truly natural, i.e., it did not depend on previous immunization with the virus or with viral antigens. Lymphocytes of EBV-seropositive and -seronegative donors were equally effective.
The relationship between the lysis of the virally superinfeeted cells and the NK system was most clearly demonstrated by cold-target competition experiments. They indicated that the same effector cells operated in both. The ability of other cell lines, including EBV-genome-negative lines, to compete for the cytotoxic effectors was clearly related to their NK sensitivity.
The mechanism of increased NK sensitivity in the virally infected cells is not known. It is not merely a sign of increased membrane fragility, because the spontaneous release did not differ between infected and noninfected target cells. Moreover, the cells were harvested 24-48 h after infection, at the time when there is not yet any appreciable cell death as a result of the superinfection process. We have excluded all cultures with <85% viable cells.
The most convincing demonstration of a specific membrane change after superinfection, as opposed to a general increase in membrane fragility comes from the competition test. Superinfected cells competed in a known NK system, the lysis of the high NK-sensitive target, Molt-4.
Although the mechanism by which EBV-superinfection increases NK sensitivity to the target is not known, extrapolation from experimental evidence indicates that interferon may play an important role (42) . Brief interferon treatment of lymphocytes increases their lytic potential, so that they may even affect otherwise NK-insensitive targets (43) . The possibility that interferon, produced by the virally infected cells, is responsible for the induction of the cytotoxic effectors is unlikely, because B95-8 virus, but not P3HR-1 virus, superinfection was found to act as an interferon inducer in EBV-carrying, latently infected lines (44) . In fact, interferon was not detected in the supernates of the P3HR-1 virus superinfected Raji cells. 2 The ability of the superinfected cells to compete in the system with Moh-4, as target, speaks for an induced membrane claange that renders the cells more sensitive to NK lysis.
Recently Pdarson et al. (39) showed Raji (V) cells are sensitive to antibodydependent lymphocytotoxicity exerted by anti-EBV antibody-positive serum and lymphocytes of healthy donors. In current experiments, we could confirm these findings and found that the ADCC effect was superimposed, over and above the viraUy induced NK sensitivity. Summary Superinfection of latently Epstein-Barr virus (EBV)-carrying Raji cells with the P3HR-1 substrain of EBV, known to induce the entry of a substantial fraction of the cells into an abortively lytic cycle, increased the susceptibility of the cells to the natural killer (NK) effect of human blood lymphocytes. Reciprocal cold-target competition tests with known NK-cell sensitive and -resistant lymphoid cell lines showed that the increased susceptibility is a result of the appearance of an NKsensitive target, rather than to a general increase in membrane fragility.
Lymphocytes of EBV-seropositive and -negative donors were equally effective killers against P3HR-1 virus-superinfected targets. EBV-induced NK sensitivity increased with time. It was a result of some event associated with the intracellular viral cycle, and not to the adherence of viral particles to the cell surface. Induction of EBV-carrying P3HR-1 cells to entry into the viral cycle with n-butyrate also increased 2 We are grateful to Dr. Wolfgang Berthold of the Karolinska Institute for testing the supernates of Raji (V) for the presence of interferon. their NK sensitivity. A transforming, noneytopathic prototype strain of EBV, B95-8, failed to increase the susceptibility of the Raji cells to NK-lysis, although it had some effect on the Daudi line.
Because NK cells can kill virus-producing cells at an early stage of the cycle, before the virus particles are assembled, they may restrict, in vivo, the spread of the virus from latently infected cells.
